Delpha Capital Management’s Trueblue TBI Stock Holding History

Delpha Capital Management’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-886	Closed	-$24K	–	1090
2017 Q4	$24K	Buy	+886	New	+$23.5K	0.03%	682

Other funds holding TBI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Delpha Capital Management's TBI Position: Q1 2018 in Review

Delpha Capital Management sold out of Trueblue (TBI) in Q1 2018, closing a stake of 886 shares — an estimated $24K sold.

Delpha Capital Management first reported a position in TBI in Q4 2017 and held it in 1 quarter. The position peaked at $24K in Q4 2017. 196 funds tracked by Wall St. Rank hold TBI as of Q1 2018.

Delpha Capital Management reported no remaining Trueblue position as of Q1 2018 after selling out during the quarter.
Delpha Capital Management sold 886 Trueblue shares in Q1 2018, an estimated $24K.
Delpha Capital Management first reported a position in Trueblue in Q4 2017 and held it in 1 quarter.
Delpha Capital Management's Trueblue position peaked at $24K in Q4 2017.
196 funds tracked by Wall St. Rank held Trueblue as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.